NUTLIN-3
NUTLIN-3 has been studied in 2 papers since 2021: none in people yet, 1 in cells, 1 review. No study of it in people or animals has been published yet. The newest paper, May 5, 2025: “ATM and p53 in aging and cancer: a double-edged sword in genomic integrity”.
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: National Cancer Institute and 2 more
- Cells1
What did studies of NUTLIN-3 find?
2Studies of NUTLIN-3 measured 2 outcomes: notch signaling and asymmetric stem cell self-renewal.
Notch signaling
upin human cells1
1 study
Notch signaling
upin human cells1
NUTLIN-3 increases notch signaling in human cells (keratinocytes).
“Nutlin-3 increased Notch signaling (NICD, Hes1)”
Cellskeratinocytesepidermis
Aging cell
Asymmetric stem cell self-renewal
upin human cells1
1 study
Asymmetric stem cell self-renewal
upin human cells1
NUTLIN-3 increases asymmetric stem cell self-renewal in human cells (aged keratinocytes) (returned to adult levels).
“Nutlin-3 (a p53 activator) returned p53 activity as well as asymmetric SC self-renewal divisions to adult levels.”
Cellsaged keratinocytesepidermis
Aging cell